3,618
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma

, , , , , , , , , ORCID Icon, & show all
Article: 2003533 | Received 07 Sep 2021, Accepted 03 Nov 2021, Published online: 22 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (18)

Chao Ma, Huan Zhao, Yang Sun, Weizheng Ding, Hui Wang, Yixin Li & Zhuoyu Gu. (2024) Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients. Cellular Signalling 117, pages 111105.
Crossref
Michael Y. Li, Lauren C. Chong, Gerben Duns, Andrew Lytle, Bruce Woolcock, Aixiang Jiang, Adèle Telenius, Susana Ben-Neriah, Waqas Nawaz, Graham W. Slack, Ingrid Elisia, Elena Viganò, Tomohiro Aoki, Shannon Healy, Gerald Krystal, Leandro Venturutti, David W. Scott & Christian Steidl. (2024) TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences 121:18.
Crossref
Jenifer Vaughan, Moosa Patel, Melinda Suchard, Maemu Gededzha, Heena Ranchod, Wayne Howard, Tracy Snyman & Tracey Wiggill. (2024) Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: the frequency and prognostic impact. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Tatsuzo Mishina, Hiroaki Miyoshi, Mai Takeuchi, Kohta Miyawaki, Kazutaka Nakashima, Kyohei Yamada, Mayuko Moritsubo, Kanako Inoue-Mitsuyama, Yasumasa Shimasaki, Teppei Imamoto, Keisuke Kawamoto, Takuya Furuta, Kei Kohno, Koji Kato, Koichi Akashi & Koichi Ohshima. (2024) Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma. Pathology - Research and Practice 254, pages 155117.
Crossref
Chun-Chun Chang, Chin-Hao Yang, Chin-Hsien Chuang, Shinn-Jong Jiang, Yin-Min Hwang, Je-Wen Liou & Hao-Jen Hsu. (2023) A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics. Communications Chemistry 6:1.
Crossref
ChaoFeng Zhang, Qi Lin, ChunTuan Li, Yang Qiu, JingYu Chen & XiongPeng Zhu. (2023) Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma. Frontiers in Immunology 14.
Crossref
Chao Ma, Zhuoyu Gu, Weizheng Ding, Feng Li & Yang Yang. (2023) Crosstalk between copper homeostasis and cuproptosis reveals a lncRNA signature to prognosis prediction, immunotherapy personalization, and agent selection for patients with lung adenocarcinoma. Aging 15:22, pages 13504-13541.
Crossref
Jieni Yu, Leihua Fu, Zhijian Zhang, Lina Ding, Li Hong, Feidan Gao, Jing Jin, Weiying Feng, Jiaping Fu, Pan Hong & Chao Xu. (2023) Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study. Clinical and Experimental Medicine 23:8, pages 4585-4595.
Crossref
Shutao Zheng, Jiajia Ma, Junna Li, Xuelian Pang, Mingfu Ma, Zhiping Ma & Wenli Cui. (2023) Lower PTEN may be associated with CD8+ T cell exhaustion in diffuse large B-cell lymphoma. Human Immunology 84:10, pages 551-560.
Crossref
Chenhui Bao, Jiayan Gu, Xin Huang, Liangshun You, Ziyang Zhou & Jie Jin. (2023) Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes. Cytokine 169, pages 156289.
Crossref
Ruiyang Ren, Chenyi Xiong, Runyu Ma, Yixuan Wang, Tianyang Yue, Jiayun Yu & Bin Shao. (2023) The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers. MedComm 4:4.
Crossref
Xue-Bin Pei, Feng-Shuang Yi, Shu-Feng Dong, Qing-Yu Chen & Xin-Yu Shi. (2023) S100A9 Regulated M1/M2 Macrophage Polarization in Interleukin-10-Induced Promotion of Malignant Pleural Effusion. Journal of Immunology Research 2023, pages 1-11.
Crossref
Lynn I. Levin, Christina M. Ramirez, Eileen L. Liao, Hongyu Guo, Bong K. Kim, Aizen J. Marrogi, Larry I. Magpantay, Elizabeth C. Breen & Otoniel Martínez-Maza. (2023) Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes. Cancer Epidemiology, Biomarkers & Prevention 32:2, pages 233-241.
Crossref
Hiroko Iizuka-Honma, Haruko Takizawa, Toru Mitsumori, Hidehiro Okura, Hisato Ishii & Masaaki Noguchi. (2023) Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib. Internal Medicine 62:3, pages 459-463.
Crossref
Kristin Stirm, Peter Leary, Daria Wüst, Dominique Stark, Nicole Joller, Ufuk Karakus, Onur Boyman, Alexandar Tzankov & Anne Müller. (2023) Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. Journal for ImmunoTherapy of Cancer 11:2, pages e006263.
Crossref
Yi-sian Lu, Po-min Chiang, Yi-ching Huang, Shiang-jie Yang, Liang-yi Hung, L.Jeffrey medeiros, Ya-ping Chen, Tsai-yun Chen, Ming-shi Chang & Kung-chao Chang. (2023) Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma. Pathology 55:1, pages 94-103.
Crossref
Na Shen, Yanfang Yu, Ruiying Zhang, Ying Guo, Mei Liu, Mengtian Tan, Jianxia Liu, Jing Bai, Li Li, Keyu Liu, Ran Wang & Jinglan He. (2022) Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma. International Journal of Clinical Practice 2022, pages 1-8.
Crossref
Wayne W. Yeh, Yin-Quan Chen, Wan-Shan Yang, Yung-Chih Hong, Sen Kao, Tze-Tze Liu, Ting-Wen Chen, Lung Chang & Pei-Ching Chang. (2022) SUMO Modification of Histone Demethylase KDM4A in Kaposi’s Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma. Journal of Virology 96:16.
Crossref